Idexx Laboratories INC /DE 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
IDEXX Laboratories' 2024 10-K filing reveals a year of growth driven by companion animal diagnostics and strategic initiatives, while navigating competitive pressures and regulatory complexities.
NASDAQ
10-K: IDEXX Laboratories Reports Fiscal Year 2023 Results, Cites Growth in Companion Animal Diagnostics
IDEXX Laboratories' 2023 annual report highlights growth in companion animal diagnostics and strategic investments, while navigating supply chain and economic challenges.